Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating mocetinostat in combination with vinorelbine for children, adolescents, and young adults with refractory or recurrent rhabdo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mocetinostat (mocetinostat)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Rhabdomyosarcoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING